Verbindungen Eli Lilly and Company

Aktien

858560

US5324571083

LLY

Pharmazeutika

Realtime-Estimate Cboe BZX 16:17:01 21.07.2026 % 5 Tage Veränd. 1. Jan.
1.162,40 USD +1,35 % Intraday Chart für Eli Lilly and Company +0,30 % +7,56 %

49

Börsennotierte Unternehmen

50

Private Unternehmen

865

Insiders

Beziehungs-Chart der börsennotierten Unternehmen: Eli Lilly and Company

Aktive Beziehungen

Vergangene Beziehungen

Verbundene börsennotierte Unternehmen: Eli Lilly and Company

Aktive Beziehungen

Vergangene Beziehungen

Beziehungs-Chart der privaten Unternehmen: Eli Lilly and Company

Aktive Beziehungen

Vergangene Beziehungen

Verbundene private Unternehmen: Eli Lilly and Company

Cerecin, Inc.

Pharmaceuticals: Major

Sorbent Therapeutics, Inc.

Pharmaceuticals: Major

Thunderbird School of Global Management

Other Consumer Services

CS-Keys, Inc.

Medical Specialties

Millendo Therapeutics US, Inc.

Pharmaceuticals: Major

Indiana University Foundation, Inc.

Investment Trusts/Mutual Funds

Duke University

Other Consumer Services

Arsenal Capital Management LP

Investment Managers

American Chemical Society

Miscellaneous Commercial Services

Twilight Venture Partners LLC

Investment Managers

Indiana University

Other Consumer Services

University of Indianapolis

Other Consumer Services

Radiant Medical, Inc.

Medical Specialties

American Cancer Society, Inc.

Miscellaneous Commercial Services

Indiana University Health, Inc.

Medical/Nursing Services

Indiana University Health Bloomington, Inc.

Hospital/Nursing Management

American Society of Clinical Oncology, Inc.

Medical/Nursing Services

National Academy of Sciences

Miscellaneous Commercial Services

American Academy of Arts & Sciences

Miscellaneous Commercial Services

National Academy of Engineering

Miscellaneous Commercial Services

National Association of Corporate Directors (Virginia)

Miscellaneous Commercial Services

Project HOPE-The-People-To-People HealthFoundation, Inc.

Medical/Nursing Services

The Business Roundtable

Miscellaneous Commercial Services

Indianapolis Museum of Art, Inc.

Other Consumer Services

The Business Council

Miscellaneous Commercial Services

Brock Capital Group LLC

Investment Managers

The Biotechnology Institute

Miscellaneous Commercial Services

Accelerator Services Corp

Investment Managers

Lilly Research Laboratories

Miscellaneous Commercial Services

Foundation for the National Institutes of Health, Inc.

Miscellaneous Commercial Services

Licensing Executives Society

Miscellaneous Commercial Services

Third Rock Ventures LLC

Investment Managers

American Diabetes Association Research Foundation, Inc.

Society of Biological Psychiatry

The Children's Museum of Indianapolis, Inc.

Miscellaneous Commercial Services

Christian Theological Seminary, Inc.

Other Consumer Services

Harvard Medical School

Other Consumer Services

Mind Trust

Miscellaneous Commercial Services

Center for Leadership Development, Inc.

Apexian Pharmaceuticals, Inc.

Pharmaceuticals: Major

Intersect Illinois

Miscellaneous Commercial Services

WCG Clinical, Inc.

Biotechnology

Kovina Therapeutics, Inc.

Miscellaneous Commercial Services

Aktive Beziehungen

Vergangene Beziehungen

Verbindungsstatistiken

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Aktivitäten der verbundenen Unternehmen

Miscellaneous Commercial Services19
Pharmaceuticals: Major19
Biotechnology19
Other Consumer Services10
Investment Managers5
Medical/Nursing Services5
Medical Specialties4
Packaged Software2
Finance/Rental/Leasing1
Agricultural Commodities/Milling1

Länder der verbundenen Unternehmen

Vereinigte Staaten90
China3
Dänemark2
Schweiz2
Vereinigtes Königreich1
Kanada1
Logo Eli Lilly and Company
Eli Lilly and Company ist einer der weltweit führenden Pharmakonzerne. Der Nettoumsatz verteilt sich wie folgt auf die einzelnen Therapiebereiche: - Endokrinologie (74 %): Produkte zur Behandlung von Osteoporose, Diabetes und Wachstumsstörungen; - Onkologie (14,4 %); - Immunologische Erkrankungen (8,1 %); - Neurologie (2,1 %): vor allem Medikamente zur Behandlung von Depressionen und Schizophrenie; - Sonstiges (1,4 %). Der Nettoumsatz verteilt sich geografisch wie folgt: Vereinigte Staaten (66,7 %), Europa (17,7 %), Japan (3,2 %), China (3 %) und Sonstige (9,4 %).
Beschäftigte
50.000